House Memorial 58 requests the New Mexico Department of Health to conduct a comprehensive study on psilocybin-based medication treatment, which has shown potential therapeutic benefits for mental health conditions such as depression, anxiety, and PTSD. The resolution outlines several key areas for investigation, including the standardization of training for medical professionals, the establishment of testing protocols for psilocybin products, and the review of existing legal and regulatory barriers. It emphasizes the need for guidelines that ensure safety, efficacy, and accessibility of psilocybin treatments, as well as considerations for public health and economic equity.

The Department of Health is also tasked with engaging medical and scientific experts, soliciting input from various stakeholders, and identifying potential funding sources for future research. A comprehensive report detailing the findings, recommended policy changes, and a proposed framework for psilocybin-based medication treatment is to be submitted, which may include pilot programs and licensing structures. The memorial aims to inform future policymaking efforts regarding the use of psilocybin in clinical settings.